Tiwari, Bishal. “FDA Approved Durvalumab for Limited-Stage Small Cell Lung Cancer”. Nepalese Journal of Cancer, vol. 9, no. 1, Apr. 2025, pp. 9-14, doi:10.3126/njc.v9i1.77006.